摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(5S)-5-ethyl-5-hydroxy-6,10-dioxo-7,19-dioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.016,20]tetracosa-1(24),2,4(9),13,15(23),16(20),21-heptaen-18-yl]methyl acetate | 860788-84-7

中文名称
——
中文别名
——
英文名称
[(5S)-5-ethyl-5-hydroxy-6,10-dioxo-7,19-dioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.016,20]tetracosa-1(24),2,4(9),13,15(23),16(20),21-heptaen-18-yl]methyl acetate
英文别名
——
[(5S)-5-ethyl-5-hydroxy-6,10-dioxo-7,19-dioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.016,20]tetracosa-1(24),2,4(9),13,15(23),16(20),21-heptaen-18-yl]methyl acetate化学式
CAS
860788-84-7
化学式
C25H22N2O7
mdl
——
分子量
462.459
InChiKey
CYLFNPPSAIGLQD-CCKNNCGLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    34
  • 可旋转键数:
    4
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    115
  • 氢给体数:
    1
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    [(5S)-5-ethyl-5-hydroxy-6,10-dioxo-7,19-dioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.016,20]tetracosa-1(24),2,4(9),13,15(23),16(20),21-heptaen-18-yl]methyl acetatesodium hydroxide 作用下, 生成 (5S)-5-ethyl-5-hydroxy-18-(hydroxymethyl)-7,19-dioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.016,20]tetracosa-1(24),2,4(9),13,15(23),16(20),21-heptaene-6,10-dione
    参考文献:
    名称:
    Synthesis and antitumor activity of the hexacyclic camptothecin derivatives
    摘要:
    A series of hexacyclic camptothecin derivatives were synthesized to test for antitumor activity as topoisomerase I inhibitor. The strategy of synthesis was used for the formation of additional furan and dihydrofuran rings fused with 9- and 10-positions of camptothecin. All of the hexacyclic camptothecins were assayed for cytotoxicity against four human tumor cell lines, HL60, BEL-7402, HCT-116, and HeLa, and showed very impressive cytotoxicity activity in vitro. Enzyme activity of the hexacyclic camptothecins was evaluated, being equal or superior to that of SN-38. The stability of four compounds was assessed in human plasma. Two of these compounds were chosen to test for antitumor activity in vivo against Sarcoma-180. The results suggested that additional furan and dihydrofuran rings could improve the antitumor activity in vitro and vivo, though the stability of the lactone ring did not increase. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.04.063
  • 作为产物:
    参考文献:
    名称:
    Synthesis and antitumor activity of the hexacyclic camptothecin derivatives
    摘要:
    A series of hexacyclic camptothecin derivatives were synthesized to test for antitumor activity as topoisomerase I inhibitor. The strategy of synthesis was used for the formation of additional furan and dihydrofuran rings fused with 9- and 10-positions of camptothecin. All of the hexacyclic camptothecins were assayed for cytotoxicity against four human tumor cell lines, HL60, BEL-7402, HCT-116, and HeLa, and showed very impressive cytotoxicity activity in vitro. Enzyme activity of the hexacyclic camptothecins was evaluated, being equal or superior to that of SN-38. The stability of four compounds was assessed in human plasma. Two of these compounds were chosen to test for antitumor activity in vivo against Sarcoma-180. The results suggested that additional furan and dihydrofuran rings could improve the antitumor activity in vitro and vivo, though the stability of the lactone ring did not increase. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.04.063
点击查看最新优质反应信息

文献信息

  • Synthesis and antitumor activity of the hexacyclic camptothecin derivatives
    作者:Heyong Gao、Xiongwen Zhang、Yi Chen、Hongwu Shen、Tao Pang、Jing Sun、Chenghui Xu、Jian Ding、Chuan Li、Wei Lu
    DOI:10.1016/j.bmcl.2005.04.063
    日期:2005.7
    A series of hexacyclic camptothecin derivatives were synthesized to test for antitumor activity as topoisomerase I inhibitor. The strategy of synthesis was used for the formation of additional furan and dihydrofuran rings fused with 9- and 10-positions of camptothecin. All of the hexacyclic camptothecins were assayed for cytotoxicity against four human tumor cell lines, HL60, BEL-7402, HCT-116, and HeLa, and showed very impressive cytotoxicity activity in vitro. Enzyme activity of the hexacyclic camptothecins was evaluated, being equal or superior to that of SN-38. The stability of four compounds was assessed in human plasma. Two of these compounds were chosen to test for antitumor activity in vivo against Sarcoma-180. The results suggested that additional furan and dihydrofuran rings could improve the antitumor activity in vitro and vivo, though the stability of the lactone ring did not increase. (c) 2005 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

鲁比替康 羧基喜树碱 盐酸拓扑替康 盐酸希明替康 盐酸伊立替康 拓扑替康-d6羧酸钠盐 拓扑替康-d5 拓扑替康 托泊替康醋酸盐; 醋酸拓扑替康; 4-乙基-4,9-二羟基-10-[(二甲基氨基)甲基]-1H-吡喃并[3',4':6,7]中氮茚并[1,2-b]喹啉-3,14(4H,12H)-二酮醋酸盐 戈维替康-沙西妥珠单抗 戈维替康-拉贝妥珠单抗 喜树碱钠盐 喜树碱杂质16 喜树碱 吉马替康 勒托替康 依喜替康甲磺酸盐 依喜替康 伊立替康杂质3 伊立替康 他克莫司 SN-38三-O-乙酰基-beta-D-葡萄糖醛酸甲酯 O-乙酰基喜树碱 N-去甲拓扑替康 N-去甲基拓扑替康-d3 9-羟基甲基-10-羟基喜树碱 9-硝基喜树碱 9-硝基-(20RS)-喜树碱 9-甲氧基喜树碱 9-甲氧基喜树碱 9-氮-10-羟基喜树碱 9-氨基喜树碱 8-乙基伊立替康 7-甲氧基甲基喜树碱 7-甲氧基喜树碱 7-甲基喜树碱 7-甲基-10-溴乙酰氨基甲基喜树碱 7-乙氧基甲基喜树碱 7-乙基喜树碱1-氧化物 7-乙基喜树碱 7-乙基-10-羟基喜树碱-D3 7-乙基-10-羟基喜树碱 7-乙基-10-(4-N-氨基戊酸)-1-哌啶)羰基氧基喜树碱盐酸盐 7,11-二乙基-10-羟基喜树碱 5-{[1-({[(4S)-4,11-二乙基-4-羟基-3,14-二氧代-3,4,12,14-四氢-1H-吡喃并[3',4':6,7]吲哚嗪并[1,2-b]喹啉-9-基]氧基}羰基)-4-哌啶基]氨基}戊酸 4-乙基-4-羟基-3,4,12,14-四氢-1H-吡喃并[3'4':6,7]吲哚嗪并[1,2-b]喹啉-3,14-二酮 4,11-二乙基-4,9-二羟基-1H-吡喃并[3’,4’:6,7]中氮茚并[1,2-B]喹啉-3,14(4H,12H)-二酮 4,11-二乙基-4,9-二羟基-1H-吡喃并[3',4':6,7]吲哚嗪并[1,2-b]喹啉-3,14(4H,12H)-二酮 20R-喜树碱 2-(氨甲基)苯乙酸盐酸盐